546 studies found for:    Wilson Disease
Show Display Options
Rank Status Study
1 Completed
Has Results
Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease
Condition: Wilson Disease
Intervention: Drug: Once a day Trientine
2 Recruiting sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis
Condition: Wilsons Disease
Interventions: Procedure: Fibroscan;   Procedure: Ultrasound;   Drug: Galactose;   Procedure: Liver biopsy;   Procedure: Functional hepatic nitrogen clearance
3 Active, not recruiting Efficacy and Safety Study of WTX101 in Adult Wilson Disease Patients
Condition: Wilson Disease
Intervention: Drug: WTX101
4 Not yet recruiting WILSTIM - DBS (WILson STIMulation - Deep Brain Stimulation)
Conditions: Severe Dystonia;   Wilson's Disease
Interventions: Device: Medtronic, Activa® PC "on";   Device: Medtronic, Activa® PC "off"
5 Recruiting The Assessment of Copper Parameters in Wilson Disease Subjects on Standard of Care Treatment
Condition: Wilson Disease
Intervention:
6 Completed
Has Results
Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.
Condition: Wilson's Disease
Intervention: Drug: NPC-02
7 Completed A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients
Condition: Wilson's Disease
Intervention: Drug: trientine dihydrochloride
8 Completed Study of Zinc for Wilson Disease
Condition: Wilson Disease
Intervention: Drug: zinc acetate
9 Recruiting Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine
Condition: Wilson Disease
Intervention: Drug: trientine dihydrochloride
10 Completed Study of Tetrathiomolybdate in Patients With Wilson Disease
Condition: Wilson Disease
Interventions: Drug: tetrathiomolybdate;   Drug: trientine
11 Recruiting Inhibitory rTMS in Dystonic Wilson Patients
Conditions: Wilson Disease;   Movement Disorders;   Repetitive Transcranial Magnetic Stimulation
Interventions: Device: Repetitive Transcranial Magnetic Stimulation (rTMS);   Other: pre and post-rTMS electroencephalogram;   Other: WCRS;   Other: handwriting scale DPRE;   Other: visual analog scale of discomfort writing and parameters collected on touchpad
12 Completed Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.
Condition: Wison's Disease
Intervention: Drug: Zinc acetate
13 Completed Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis
Condition: Wilson's Disease
Intervention: Genetic: allogeneic mesenchymal stem cell transplantation
14 Recruiting Evaluation of Patients With Liver Disease
Conditions: Biliary Liver Cirrhosis,;   Hemochromatosis;   Hepatitis;   Hepatolenticular Degeneration;   Liver Disease
Intervention:
15 Recruiting ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders
Conditions: Movement Disorders;   Essential Tremor;   Holmes Tremor;   Parkinson's Disease;   Wilson's Disease;   Huntington's Disease;   Dystonia;   Tardive Dyskinesia;   Orofacial Dyskinesias
Intervention: Device: Transcranial ExAblate System
16 Unknown  Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)
Conditions: SIRS;   Sepsis;   Liver Disease
Intervention:
17 Completed A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris
Condition: Psoriasis
Intervention: Drug: Tetrathiomolybdate (TM)
18 Withdrawn A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: Vemurafenib and Trientine
19 Recruiting Shear Wave Sonoelastography in Pediatric Liver Fibrosis
Conditions: Sonoelastography;   Elastography;   Elastograms;   Liver Fibrosis;   Hepatic Fibrosis;   Cirrhosis;   Pediatrics
Intervention: Device: Shear wave sonoelastography
20 Completed Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver
Condition: Cancer
Interventions: Drug: Disulfiram;   Drug: Copper Gluconate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years